Back to search

Article

DNA Polymerase Beta Catalytic and Fidelity Mutations Drive Platinum Specific Drug Sensitivity

2026-06-19

Abstract excerpt

With the advent of genome sequencing and its widespread use in the clinic, there is a great need to identify mutational biomarkers that predict therapeutic responses. DNA polymerase Beta (Polβ) and the base excision repair (BER) pathway have been previously implicated as modulators of response to platinum-based chemotherapies and are mutated in as high as 30% of cancers. Here, we show in a triple-negative breast c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
14ccafe5-e11c-552d-b5e5-b016d9924e23
DOI
10.64898/2026.06.15.732403
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DNA Polymerase Beta Catalytic and Fidelity Mutations Drive Platinum Specific Drug SensitivityDOI 10.64898/2026.06.15.732403
Select a neighboring publication to make it the new centre.